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Abstract
Clostridium chauvoei is the causative agent of blackleg, a wide spread serious infection of cattle and sheep with
high mortality. In this study we have analyzed the sialidase activity of the NanA protein of C. chauvoei and cloned
the sialidase gene nanA. Sialidase is encoded as a precursor protein of 722 amino acids with a 26 amino acid
signal peptide. The mature sialidase has a calculated molecular mass of 81 kDa and contains the carbohydrate
binding module 32 (CBM32, or F5/8 type C domain), the sialic acid binding module CBM40 and the enzymatically
active sialidase domain found in all pro- and eukaryotic sialidases. Sialidase activity does not require the CBM32
domain. The NanA protein is secreted by C. chauvoei as a dimer. The nanA gene was found to be conserved and
sialidase activity was found in C. chauvoei strains isolated over a period of 50 years from various geographical
locations. Antiserum directed against a recombinant 40 kDa peptide containing CBM40 and part of the
enzymatically active domain of NanA neutralized the secreted sialidase activity of all C. chauvoei strains tested.
Introduction
Clostridium chauvoei is an anaerobic, endospore-form-
ing Gram-positive bacterium known to be the causative
agent of blackleg, a severe disease with high mortality
affecting young cattle and sheep of any age. While C.
chauvoei infections are specifically found in ruminants,
a case of human fulminant gas gangrene caused by C.
chauvoei was recently described [1]. Ingestion of C.
chauvoei spores is probably the most common form of
exposure and infected ruminants do not directly trans-
mit the disease to other animals. The endospores of C.
chauvoei can lie dormant in the soil for years and, after
ingestion by the animal, they are assumed to cross over
the gastro-intestinal tract, enter the bloodstream and
finally migrate in various organs and muscles, where
they remain dormant until stimulated to cause disease
[2]. These spores are only activated in a low oxygen
environment, such as that of damaged or bruised tissue
in cattle. In sheep, blackleg is frequently associated with
wounding, such as at shearing cuts, tail docking and cas-
tration site [3]. Once these stimulating events occur, the
spores in the infected tissue germinate and multiply into
the disease-causing C. chauvoei bacteria. Then, the dis-
ease progresses rapidly, with the infected animal dying
in 12 to 36 h after the appearance of the first symptoms
[4]. The molecular mechanisms of blackleg are not
clearly understood. Due to the peracute evolution with
severe oedematous lesions restricted to the local area,
fever, loss of appetite, lameness and depression observed
in blackleg outbreaks, it is speculated that virulence of
C. chauvoei is caused by rapid spread of the activated,
vegetative form of the bacterium in the infected tissue,
followed by the production of potent toxins [4,5].
Although sialidases and toxins produced by C. chauvoei
are believed to play a significant role in the spread of
the pathogen and in the induction of lesions in affected
tissues [5], they have not yet been characterized at the
molecular and genetic level. It has to be mentioned here
that, to date, only a few DNA sequences of C. chauvoei
have been deposited in DDBJ/EMBL/GenBank databases
including the 16S and the 23S rRNA genes, the 16S-23S
rRNA spacer region, and the flagellin gene [6,7].
Sialidases, or neuraminidases (EC 3.2.1.18), are
enzymes that cleave N-acetylneuraminic acid from car-
bohydrate polymers, such as mucin, glycoproteins, gang-
liosides and other sialoglycoconjugates, located on many
mammalian cell membranes. The mature sialidase is
generally composed of three main domains (Figure 1).
At its N-terminal end, it contains the F5/8 type C
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binding module 32) or discoidin domain, that appears to
be primarily involved in binding of terminal galacto-
configured sugar residues and is also found in the C.
perfringens sialidase NanJ [8]. The central domain con-
tains a CBM40 module (or lectin-like sialic acid binding
domain) that was shown to be specific for binding sialic
acid residues in NanJ of C. perfringens [8]. The enzyma-
tically active site of sialidases is in the C-terminal end
that contains the usual catalytic residues that are com-
mon to all sialidases [9-11], including a catalytic nucleo-
phile tyrosine, an arginine triad that interacts with the
carboxylate group of sialic acid, a tryptophan residue
that forms a weak H-bond with the glycerol side chain
of sialic acid, and an aspartic acid that forms H-bonds
with the four OH-groups of sialic acid. Furthermore, the
enzymatically active domain contains four “Asp-boxes”
[10] characterized by the motif Ser-X-Asp-X-Gly-X-
Thr-Trp, and the first arginine of the catalytic triad of
sialidases generally belongs to a RIP (Arg-Ile-Pro) motif
[12].
Sialidases have been found in viruses, bacteria, proto-
zoa, fungi and metazoans [13]. In viruses, parasites and
bacteria, sialidases are thought to be important for sur-
vival and pathogenicity of the organisms [14]. It has
been established that viral sialidases have a central role
in the pathogenesis of influenza [14,15]. The importance
of sialidase in respiratory tract infections has been
demonstrated for two bacterial species: Streptococcus
pneumoniae and Pseudomonas aeruginosa. The neura-
minidases (sialidases) NanA and NanB of S. pneumoniae
have been shown to be essential for successful coloniza-
tion of both upper and lower respiratory tract and for
pneumococcal survival in the blood using an outbred
MF1 mouse or chinchilla model [16,17]. The sialidase
produced by P. aeruginosa has been shown to be a
critical factor for colonization of the upper respiratory
tract. It has also been shown that viral neuraminidase
inhibitors blocked biofilm production and the bacterial
colonization by P. aeruginosa [18]. Recently, Mally and
colleagues [19] demonstrated the impact of sialidase in
Capnocytophaga canimorsus, a commensal canine bac-
terium of the oral flora, that can cause severe septicae-
mia and meningitis in humans [20]. Wild type C.
canimorsus is dependent on a surface exposed sialidase
for growth and persistence in a murine infection model,
whereas a sialidase deficient C. canimorsus mutant was
unable to grow and persist in mice [19]. Sialidase may
have an important role in blackleg by degrading tight
junctions upon cleavage of sialic acids at a high rate,
thus allowing the bacterium to spread through host tis-
sue [5]. A sialidase activity has been reported in C.
chauvoei [21], but the sialidase enzyme has not yet been
characterized in detail [22,23]. Furthermore, the molecu-
lar and genetic basis of sialidase in C. chauvoei is still
unclear.
This study reports the cloning of the nanA sialidase
gene from C. chauvoei, its expression and the character-
ization of the sialidase NanA protein. Under native con-
ditions in bacterial culture medium, C. chauvoei
sialidase is found as a 150 kDa protein, in the form of a
dimer of two NanA peptides with an apparent molecular
mass of 72 kDa.
Materials and methods
Strains and culture conditions, DNA extraction and
sequence analysis
The seven C. chauvoei strains used in this study are
listed in Table 1. The C. chauvoei strains were grown
anaerobically on Tryptic Soy Agar (TSA) medium con-
taining 5% sheep erythrocytes (bioMérieux, Geneva,
Switzerland) or in TGY broth (3% tryptic soy broth
CBM32
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sialic acid binding domain Si
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acatcgtttacatggtaaaatttacatggaatataaaatatgtaaaaaggtggaagcgaATG
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R
I
P
enzymaticactive domain
40 kDa peptide
enzymatically active recombinant protein
Figure 1 Schematic representation of the NanA sialidase of C. chauvoei. Upper part: DNA sequence of the promoter region of nanA of
strain JF4135 with -35 and -10 boxes and the ribosome binding site (RBS) underlined. The translational start codon (ATG) is indicated by upper
case letters. Lower part: main domains of the NanA polypeptide. Numbers refer to amino acid positions and black bars represent the
characteristic “Asp-boxes”. Si is the signal sequence and RIP indicates the position of the first Arg residue of the catalytic triad with the
characteristic Arg-Ile-Pro sequence. The horizontal lines indicate the part of NanA that was expressed as a recombinant 40 kDa polyhistidine-
tailed peptide to produce monospecific polyclonal antibodies in rabbits (upper) and the part of NanA expressed as enzymatically active
recombinant protein (lower).
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cose (Sigma-Aldrich chemical, St. Louis, MO, USA), 1%
yeast extract (Becton Dickinson AG), and 0.1% L-
cysteine (Sigma-Aldrich chemical)) at 37°C for up to 72
h. Escherichia coli strains were grown in Luria-Bertani
(LB) broth or on LB agar at 37°C. Antibiotics (ampicil-
lin, 100 μg/mL) were added for selection of E. coli carry-
ing recombinant plasmids.
DNA from C. chauvoei strains was extracted by the
guanidium thiocyanate method [24]. Ligation, subclon-
ing, plasmid extraction of the DNA fragments and agar-
ose gel electrophoresis (0.7%) were performed as
described [25]. Plasmid extraction from recombinant E.
coli clones was done by alkaline lysis using a Miniprep
kit (PeqLab Biotechnologie GmbH, Erlangen, Germany).
Sequence analysis was performed using an ampli-Taq FS
dye terminator kit (Applied Biosystems, Foster City, CA,
USA) and the universal primers complementary to the
T3 and T7 promoters flanking the multiple cloning site
of pBK-CMV, or primers that were derived from
obtained DNA sequences.
Comparisons of DNA sequences and their correspond-
ing amino acid (aa) sequences with DDBJ/EMBL/Gen-
Bank databases were performed using BLAST analysis
[26]. The molecular mass and theoretical isoelectric
points (pI) of the sialidase were calculated using Prot-
Param [27]. Pattern and profile searches were carried out
at the online servers Motif Scan [28] and InterProScan
[29]. The presence and location of signal peptide cleavage
sites in the amino acid sequence were predicted with the
program SignalP 3.0 [30]. Prediction of transmembrane
helices and topology of the sialidase was carried out with
the programs HMMTOP 2.0 [31] and Phobius [32]. The
neighbour joining tree of aa sequences from clostridial
sialidases was constructed with multiple amino acid
sequence alignment by ClustalW2 [33].
Production of rabbit serum directed against proteins
secreted by C. chauvoei
A culture (100 mL) of C. chauvoei strain JF1863 (Table
1; type strain ATCC10092) grown for 72 h in TGY
medium was centrifuged at 9000 × g at 4°C for 20 min.
Proteins in the supernatant were precipitated overnight
at 4°C upon addition of 70% (w/v) ammonium sulphate.
Precipitated proteins were sedimented by centrifugation
for 10 min at 12000 × g. The pellet was suspended in 10
mL of dialysis buffer (0.1 M Na-bicarbonate, pH 8.3,
0.25 M NaCl) and then dialyzed overnight at 4°C with
gentle stirring. Aliquots of 500 μL containing 200 μgo f
dialyzed proteins or 50 μg of purified recombinant pro-
tein were mixed with the same quantity of Gerbu adju-
vant (Gerbu Biotechnik GmbH, Gaiberg, Germany) for
immunizing rabbits three times at intervals of two
weeks. Rabbits were bled two weeks after the last immu-
nization and all serum samples were then incubated for
30 min at 56°C to inactivate complement.
Construction of a genomic library, cloning of the nanA
gene and DNA sequence analysis
Genomic DNA of C. chauvoei strain JF4135 (other
name: C6 O/D1126/04; Table 1), a strain that caused
acute blackleg in Switzerland in 2004, was partially
digested with Sau3AI and fragments from 2 to 4 kb
were selected to construct a genomic library, using
BamHI-digested l-ZAP-express vector arms, which was
packaged with the Gigapack-11 packaging system (Stra-
tagene, La Jolla, CA, USA). The phage library was plated
using standard protocols on the E. coli strain XL-1 Blue
MRF’. Screening of transformed E. coli was performed
with rabbit serum against secreted proteins of C. chau-
voei, raised as described above, used at a dilution of
1:100. Positive clones were amplified and finally sub-
jected to in vivo excision using the f1 helper phage in E.
coli strain XLOLR to obtain phagemid clones in expres-
sion vector pBK-CMV. A clone that strongly reacted
with the rabbit hyper-immune serum was revealed to
contain a 1.7 kb fragment whose sequence showed simi-
larity to the sialidase gene of Clostridium septicum [34],
as determined by BLAST analysis. The remaining part
of the sialidase gene, named nanA (neuraminidase A),
was detected by screening the same genomic DNA
library by DNA:DNA hybridization with a 512 bp digox-
igenin-labelled probe amplified from the cloned 1.7 kDa
fragment with primers digSiaCC_605F (TTACTAGTG-
GAAATGGTG) and digSiaCC_1117R
(CTTTTGCTGTAGTTTCAC). Digoxigenin labelling of
the probe was done according to the manufacturer’s
instructions (Roche Diagnostics, Rotkreuz, Switzerland).
Upon analysis of few clones harbouring partial
sequences of nanA by primer walking with an ABI
Prism model 3100 genetic analyzer (Applied Biosys-
tems), the complete DNA sequence of the cloned gene
and the sequences upstream and downstream were
determined. Sequence alignment and editing were per-
formed using the software Sequencher 3.0 (GeneCodes,
Table 1 Clostridium chauvoei strains used in this study
Internal
reference
Strain Description and origin
JF1863 ATCC10092 type strain
JF2697 MT blackleg outbreak, Brazil, 2002
JF3703 595E acute blackleg, New Zealand,
1959
JF4135 C6 O/D1126/
04
acute blackleg, Switzerland, 2004
JF4251 AN2548/02 blackleg outbreak, Sweden, 2002
JF4252 AN1717/06 blackleg outbreak, Sweden, 2006
JF4253 AN2500/07 blackleg outbreak, Sweden, 2007
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strain JF3703 (other name: 595E; Table 1), a highly viru-
lent strain isolated in New Zealand in 1959, was deter-
mined by PCR amplification and DNA sequence analysis
using the same primers as for strain JF4135. The
sequence data of the sialidase gene nanA have been
deposited in the EMBL Nucleotide Sequence Database
(European Bioinformatics Institute, Cambridge, UK)
under accession numbers FM213081 for strain JF3703
and FM213082 for strain JF4135.
PCR analysis
T h ep r e s e n c eo ft h enanA gene of C. chauvoei was
demonstrated in all seven C. chauvoei strains examined
(Table 1) by PCR using the primers SiaCC_1371F
(ATCAGCAATAGATACATC) and SiaCC_1789R
(TGACCTCTTCCTGGTCCTGT). PCR was carried out
in 30 μL reaction mixtures containing 1 × reaction buf-
fer B (supplied with FIREPol
® DNA polymerase), 2.5
mM MgCl2, 0.4 mM of each primer, 1 mM dNTPs, and
2.5 U of FIREPol
® polymerase (Solis BioDyne, Tartu,
Estonia). Approximately 100 ng of genomic DNA was
added as template. Cycling conditions on a 9800 Fast
Thermal Cycler (Applied Biosystems) were 3 min dena-
turation at 94°C, followed by 35 cycles at 94°C for 30 s,
56°C for 30 s and 72°C for 60 s. A final extension step
for 7 min at 72°C was included. Amplicons were puri-
fied with the High pure PCR product purification kit
(Roche Diagnostics).
Cloning and expression of the CBM40 module of the C.
chauvoei sialidase and production of antibodies
To generate polyclonal antibodies directed against the
CBM40 sialic acid binding domain of NanA, the coding
region from nt position 367 to 1389 of the nanA gene
(corresponding to aa 123 to 463), which also includes
the first Arg residue and the RIP (Arg-Ile-Pro) motif of
the catalytic site of sialidases, was amplified from C.
chauvoei strain JF4135 using the primers Sia40_NcoIF
(ggtcccatggGTATAAAAGAATACAAAATTTATGCG)
and Sia40_HindIIIR (cccaagcttGATGTATCTATTGCT-
GATGATGCTCC) (nucleotides in lower case are exten-
sions and underlined nucleotides are recognition sites
for the restriction enzymes NcoIo rHindIII). The result-
ing PCR product was cloned into the pGEM-T easy vec-
tor (Promega Corp., Madison, WI, USA) and
transformed into E. coli strain DH5a. Recombinant plas-
mids with the correct sequence were then digested with
NcoI and HindIII, and the DNA fragments were inserted
into the expression vector pETHIS-1 [35]. The cloned
insert was sequenced to ensure correct fusion with the
vector’s poly-His codons before being transformed into
E. coli BL21(DE3) cells [36] for expression. Induction
and subsequent purification of the recombinant 40 kDa
His-tagged protein was performed as described [37].
Purified 40 kDa His-tagged protein was used to immu-
nize rabbits as described above.
SDS-PAGE and immunoblotting
Pellets and supernatants of C. chauvoei strains (Table 1)
incubated at 37°C under anaerobic conditions in TGY
medium for 72 h were examined by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) and
immunoblotting on nitrocellulose membranes (Bio-Rad
Laboratories, Hercules, CA, USA). Proteins were sepa-
rated on 12% acrylamide gels by SDS-PAGE under
denaturing or non-denaturing conditions [38]. Non-
denaturing gel electrophoresis was performed in the
absence of reducing agents. In order to detect the siali-
dase, the immunoblot membranes were incubated with
rabbit polyclonal anti-sialidase 40 kDa peptide serum
(diluted 1:1000), followed by incubation with a phos-
phate- or peroxidase-conjugated goat anti-rabbit IgG
heavy and light chains (Kirkegaard & Perry Laboratories,
Gaithersburg, MD, USA) diluted 1:2000.
Expression of functional NanA in E. coli DH5a
To express enzymatically active recombinant NanA, we
amplified the part of the nanA gene from nt position 364
to 2316 (corresponding to aa 122 to 772), encoding
CBM40 (sialic acid binding module) and the enzymatically
active domain but not CBM32 (Figure 1), from C. chauvoei
strain JF4135 using the primers SiaCC_BssHIIF
(ttggcgcgcAATGATAAAAGAATACAAAATTTATGCG)
and SiaCC_HindIIIR (cccaagcttTATAAATTTC-
CATTTTCTGTTATTAAACC) (nucleotides in lower case
are extensions containing recognition sites for the restric-
tion enzymes BssHII and HindIII, respectively, that are
underlined). The resulting PCR product was cloned into
the vector T-easy (Promega Corp.) and transformed into E.
coli strain DH5a. Recombinant plasmids with the correct
sequence were then digested with BssHII and HindIII, and
the DNA fragment was ligated into the multiple cloning
site of vector pFastBac1 (Invitrogen, Carlsbad, CA, USA)
digested with BssHII and HindIII. Vector pFastBac1 was
chosen in order to express active NanA in both prokaryotic
and eukaryotic cells, such as insect cells, utilizing the bacu-
lovirus expression system. This plasmid harbours the poly-
hedrin promoter from the baculovirus, which was shown
to also have an adequate ability for initiating expression of
introduced heterologous genes in E. coli [39]. E. coli DH5a
was transformed with pFastBac1::nanA and with empty
vector pFastBac1. Sialidase activity of recombinant E. coli
was measured using the sialidase spot test described below.
Sialidase activity tests
The fluorogenic substrate 2’-(4-methylumbelliferyl)-a-d-
N-acetylneuraminic acid (MU-Neu5Ac) (Sigma-Aldrich
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test [40] and in a fluorimetric determination in culture
fluids [41,42].
For the spot test, a working solution of 15 μMM U -
Neu5Ac in 0.17 M sodium acetate buffer (pH 6.5) was
prepared. Either colonies of C. chauvoei, recombinant E.
coli,o r1 0μL of supernatant from liquid C. chauvoei
cultures were spotted onto 1-mm Whatman filter paper
that had been previously moistened with the MU-
Neu5Ac working solution, and then incubated at 37°C
for 15 min. The reactions were stopped (0.085 M gly-
cine, 0.2 M sodium carbonate, pH 9.4), the filter papers
air-dried and fluorescence observed under a UV light
(360 nm excitation wavelength). Observable bright blue
fluorescence was recorded as positive. Anti-sialidase 40
kDa peptide serum or pre-immune serum (both diluted
1:10) obtained from the same rabbit were spotted onto
the filter paper, at some distance from the bacterial
spots but still partially overlying them, to assess the neu-
tralizing effect of the anti-sialidase serum against siali-
dase activity.
For the fluorimetric determination of culture fluid sia-
lidase activity, strain JF4135 was grown anaerobically for
1 day at 37°C. After cell counting (OD600 nm), the cul-
ture was centrifuged at 2000 × g for 10 min and the
supernatant was centrifuged again at 15000 × g for 15
min to obtain cell-free supernatant. The reaction was
performed in a total volume of 100 μL containing 30 μL
of 0.1 M sodium acetate buffer (pH 6.0), 10 μLo fa1
mM MU-Neu5Ac solution in water and 60 μL of sample
(each sample consisted of 54 μL cell-free supernatant
pre-incubated for 30 min at 37°C with 6 μL of anti-siali-
dase or pre-immune serum (at several dilutions) prior to
fluorimetric quantification of sialidase activity). Samples
were incubated at 37°C for 60 min and quantification of
sialidase activity was carried out kinetically (at 30 sec
intervals) in triplicate with an FLx800 fluorescence
microplate reader (BioTek, Luzern, Switzerland). Liber-
ated 4-methylumbelliferone (MU) was quantified at 360/
40 nm excitation and 460/40 nm emission in relation to
a calibration curve obtained with MU standards (serial
2-fold dilutions ranging from 0 to 100 μM).
Results
Characteristics of the Clostridium chauvoei sialidase
The full length sialidase gene nanA of C. chauvoei strain
JF4135 consists of 2319 bp. A strong ribosome binding
site (AGGTGG) is found eight bases upstream of the
putative start codon ATG and is preceded by a potential
clostridial promoter sequence including a TATA box
(TATAAAAT) and a -35 element (TTTACA) (Figure 1).
The NanA protein derived from the nucleotide sequence
consists of 772 aa, with a predicted molecular mass of
84.0 kDa and a pI of 4.89. The aa sequence derived
from the DNA sequence reveals a leader sequence pep-
tidase cleavage site between position 26 and 27 (Ile-Tyr-
Ala↓Asp-Ile), which is characteristic for secreted pro-
teins of Gram-positive bacteria. The putative mature sia-
lidase consists of 746 aa with a calculated molecular
mass of 81.1 kDa. At its N-terminal end, aa residues 42
to 186 (numbering always includes the aa residues of
the precursor) form the CBM32 module (Figure 1). In
the central portion of NanA, aa 190 to 370 form the
CBM40 module. The enzymatically active site ranging
from aa 384 to 770 contains the usual catalytic residues,
common to all sialidases: Tyr-728 (catalytic nucleophile),
Arg-400, Arg-613 and Arg-693 (forming the arginine
triad, whereas Arg-400 is contained in the RIP motif),
Trp-577 (that interacts with the glycerol side chain of
sialic acid) and Asp-582 (that forms H-bonds with the
four OH-groups of sialic acid). Moreover, the four “Asp-
boxes” are found at aa positions 437-444, 570-577, 634-
641 and 707-714 (Figure 1).
T h ea as e q u e n c eo fN a n Af r o ms t r a i nJ F 3 7 0 3d i f f e r s
from that of JF4135 at 18 aa loci that do not affect cata-
lytic domains or “Asp-boxes”. Amino acid similarities to
NanA were found with several clostridial sialidases (Fig-
ure 2). Most closely related is the sialidase from C. septi-
cum with an aa homology of 79% and 82% identical
nucleotides at the gene level.
Sialidase activity and presence of nanA in C. chauvoei
strains
All seven C. chauvoei strains used (Table 1) contained
the nanA gene as revealed by PCR. Sequencing of the
amplicons revealed minor nucleotide changes that do
not affect however the size of expressed proteins. Mono-
specific polyclonal antibodies directed against the
recombinant 40 kDa peptide representing the CBM40
domain of NanA (Figure 1) reacted on standard immu-
noblots containing supernatants of C. chauvoei cultures
of all strains with a 150 kDa and to a lesser extent with
a 72 kDa band (Figure 3 shows the results for strains
JF3703 and JF4135). The latter band was somewhat
smaller than the predicted molecular mass of 81 kDa for
mature NanA calculated from the DNA sequence of the
nanA gene. When non-denaturing gels were used for
the immunoblots, only the 150 kDa band was detected
(Figure 3), indicating that the C. chauvoei sialidase is a
150 kDa dimer of the 72 kDa NanA polypeptide.
All strains were positive in the sialidase spot test,
showing the same spot diameter. Sialidase activity was
observed directly with bacterial colonies spotted onto
the filter, as well as with supernatant of C. chauvoei cul-
tures grown in TGY medium (Figure 4), showing that
sialidase was secreted. Moreover, when part of the nanA
gene encoding the lectin-like sialic acid binding module
CBM40 and the enzymatically active domain, but not
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formed into E. coli strain DH5a, sialidase activity was
found in culture supernatant of the recombinant E. coli
strain harbouring the plasmid pFastbac1::nanA but not
in the E. coli control strain harbouring the empty vector
pFastBac1 only (not shown). Sialidase activity secreted
by all C. chauvoei s t r a i n su s e di nt h i ss t u d ya n db y
recombinant E. coli was neutralized by monospecific
polyclonal antiserum raised in rabbit against the recom-
binant 40 kDa peptide (Figure 4 shows the results for
strain JF4135), showing the functional impact of the
CBM40 module covered by this peptide.
Similarly, the anti-sialidase 40 kDa peptide serum had
an inhibitory effect on the sialidase activity in culture
supernatants of C. chauvoei as determined by a kinetic
fluorimetric assay (Figure 5 shows the results for strain
JF4135). The assay monitored the cleavage of the glyco-
sidic linkage of 100 μM of substrate MU-Neu5Ac upon
incubation at 37°C for 60 min with C. chauvoei culture
fluids. While the culture fluid of 5 × 10
7 cells was able
to release approximately 10 μM MU from the substrate,
anti-sialidase serum could inhibit this activity by 60%
when diluted 1:10 (Figure 5). Anti-sialidase serum
diluted 1:100 and 1:1000 inhibited the activity by 40%
and 20%, respectively. As expected, pre-immune serum
from the same rabbit, used as a control at different dilu-
tions, did not affect the C. chauvoei culture fluid siali-
dase activity.
Discussion
Due to the rapid progression and severity of blackleg, it
is appropriate to assume that potent toxins are responsi-
ble for the rapid spread of C. chauvoei and for the
severe lesions that are produced by the pathogen in the
target tissues. It has previously been hypothesized that
sialidase may have an important role in blackleg by aid-
ing the spread of the bacterium through the tissue [5].
Furthermore, sialidases from S. pneumoniae, P. aerugi-
nosa and C. canimorsus have been demonstrated to be
crucial for infection and colonization of the host
[16-19]. From these data, it can be hypothesized that
C. sordellii sialidase
C. perfringens NanH
C. tertium sialidase
C. perfringens NanI
C. perfringens NanJ
C. chauvoei NanA
C. septicum sialidase
0.10
Figure 2 Neighbour joining tree of clostridial sialidases.T h e
tree was constructed by ClustalW2 with gap open penalty of 10
and gap extension penalty of 0.05. The bar (0.10) represents
substitutions per site. The following sialidase amino acid sequences
were aligned: C. chauvoei (strain JF4135; this study), C. tertium
(GenBank: CAA69951), C. sordellii (GenBank: AAB38298), C. septicum
(GenBank: CAA44916), C. perfringens NanH (GenBank: P10481), C.
perfringens NanI (GenBank: NP_561641) and C. perfringens NanJ
(GenBank: NP_561469).
AB
Std  1     2      1       2
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95
72
55
43
34
170
kDa
130
95
72
55
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34
170
kDa
Figure 3 Dimer form of NanA. Western blot with anti-sialidase 40
kDa peptide serum under denaturing conditions (panel A) showing
the 72 kDa monomer, or under native conditions (panel B) showing
the 150 kDa dimer. Lane 1, C. chauvoei strain JF3703; lane 2, C.
chauvoei strain JF4135.
15 mm
Figure 4 Sialidase neutralization spot test. The solid rings show
the diffusion zone of the culture supernatant of C. chauvoei strain
JF4135. The dotted rings show the diffusion zone of: left, anti-
sialidase 40 kDa peptide serum; right, pre-immune serum from the
same rabbit.
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role in the early stage of blackleg infection by degrading
tight junctions upon cleavage of sialic acid from mucins
and glycoproteins in the infected tissue. Cleavage of sia-
lic acid results in decreased rigidity of the cell surface,
thereby facilitating cell motility and thus rendering the
target site vulnerable to massive attack by the pathogen
that rapidly spreads in the infected tissue. Then, the
production of toxins such as hyaluronidases (gamma-
toxins), deoxyribonucleases (beta-toxins) and oxygen-
l a b i l eh e m o l y s i n sb yt h e s eb a c t e r i am a yg i v er i s et o
necrosis of the infected muscles and alteration of vascu-
lar endothelium, both known as characteristic signs of
blackleg [5].
Sialidase activity of C. chauvoei was reported pre-
v i o u s l y[ 2 1 ]b u tt h ec o r r e s p onding enzyme was charac-
terized only biochemically and not genetically [22,23].
Our genetic and biochemical data reveal a sialidase,
named NanA, in C. chauvoei that is a 150 kDa homodi-
mer composed of two identical polypeptides of an
apparent molecular mass of 72 kDa. Differences between
the predicted size calculated from the nucleotide
sequence of nanA (81 kDa) and the apparent size
observed by SDS-PAGE (72 kDa) have previously been
reported for several bacterial sialidases, such as S. pneu-
moniae [43,44], Clostridium tertium [45] and C. septi-
cum [46]. Native sialidase enzymes from bacteria are
described as multimers, mostly dimers, of polypeptides
Figure 5 Fluorimetric determination of culture fluid sialidase activity. Cell-free supernatant of C. chauvoei strain JF4135 was pre-incubated
with different dilutions of anti-sialidase 40 kDa peptide serum or pre-immune serum from the same rabbit. Liberated 4-methylumbelliferone
(MU) obtained upon cleavage of substrate MU-Neu5Ac with sialidase in culture fluids of 5 × 10
7 C. chauvoei cells was recorded at 30 sec
intervals. Black circles, no pre-incubation with antibodies; white triangles, pre-incubation with pre-immune serum (diluted 1:10); squares, pre-
incubation with anti-sialidase serum (white, diluted 1:1000; gray, diluted 1:100; black, diluted 1:10). Plots are the mean of three kinetic
measurements of sialidase activity.
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kDa [45], which agrees with our data for the sialidase of
C. chauvoei. Although the 300 kDa sialidase described
by Heuermann et al. [22] might represent a multimer of
the 72 kDa NanA protein, we did not detect such a pro-
tein on our immunoblots. The sialidase NanA of C.
chauvoei is most closely related to the sialidase of C.
septicum and to NanJ and NanI of C. perfringens (Figure
2), the structures of which have been studied in detail
[8,10]. In this respect, it is interesting to note that C.
chauvoei and C. septicum are phylogenetically very clo-
sely related [47] and at one time were classified pheno-
typically as the same species [48].
The C. chauvoei sialidase NanA displays the same
motifs as the C. perfringens sialidase NanJ [10]. NanA
has a CBM32, or F5/8 type C domain, located at posi-
tion 42 to 186, which is absent in C. perfringens NanI
[8,10]. This domain does not seem to be essential for
enzyme activity as demonstrated by the sialidase activity
of the recombinant NanA without CBM32. This is in
agreement with recent data that classify the CBM32
module as a special domain that is involved in binding
complex sialic acid substrates containing galactose resi-
dues [9,11]. The lectin-like sialic acid binding module
CBM40 and the enzymatic active domains show strong
similarities to NanI and NanJ of C. perfringens.T h el a t -
ter domain contains all the characteristic residues neces-
sary for sialidase activity, as seen in all prokaryotic and
eukaryotic sialidases [11], including the catalytic arginine
triad with the RIP motif on the first of the three Arg
residues, and the characteristic “Asp-boxes”. Antibodies
directed against the recombinant 40 kDa peptide that
includes the entire CBM40 module and part of the
enzymatically active domain of NanA, in particular the
RIP motif (Figure 1), neutralized the secreted sialidase
activity of C. chauvoei strains (Figures 4 and 5), con-
firming their importance in sialidase activity. Further-
more, this result suggests that NanA is the sole or
predominant secreted sialidase of C. chauvoei.I fo t h e r
sialidases antigenically similar to NanA were present in
C. chauvoei, supplementary protein bands would have
been detected on immunoblots using the same anti-
serum against the 40 kDa peptide, but no such addi-
tional sialidases were observed (Figure 3).
Since prevention of contact of ruminants with the
endospores of C. chauvoei that are present in the con-
taminated soil is virtually impossible, vaccination is the
only preventive measure to effectively control blackleg.
Current vaccination strategy against this disease relies
on the use of a suspension for injection containing for-
maldehyde-inactivated cultures of virulent strains of C.
chauvoei and culture supernatant, generally presented in
polyvalent formulations. These vaccines are efficient but
the particular antigens necessary to induce protective
immunity against blackleg are unknown, thus requiring
expensive work-intensive animal models for potency
testing of vaccine batches. Moreover, molecular quality
control of current vaccines, design of novel vaccines and
diagnostic tests are mainly hampered by the lack of
basic knowledge on the molecular mechanisms of
pathogenicity of C. chauvoei. Studies on the role of siali-
dases of Streptococcus pneumoniae in otitis media in
children and of Propionibacterium acnes in acne vul-
garis have shown that sialidases of these species induce
antibodies that inhibit propagation of bacteria in the
host tissues [17,49,50]. When challenged, chinchillas
vaccinated with recombinant sialidase from S. pneumo-
niae, expressed in E. coli, showed significantly reduced
colonization and middle ear invasion compared with
non-vaccinated individuals. Taken together, these find-
ings in animal studies and the data of the present work,
whereby antibodies raised against the sialidase 40 kDa
peptide of C. chauvoei effectively neutralized the activity
of the infectious agent, indicate that sialidase of C.
chauvoei may be a good vaccine candidate to protect
ruminants against the pathogen and to prevent the
occurrence of blackleg. Furthermore, we expect that a
combination of this antigen with one or more polypep-
tides derived from the toxins produced by C. chauvoei
may have a potentiated protective effect against
blackleg.
Acknowledgements
This study was financially supported by a grant from Intervet/Schering-
Plough Animal Health. The authors are grateful to Elisabeth Bagge (National
Veterinary Institute, Uppsala, Sweden) for kindly providing isolates from
Swedish outbreaks of blackleg.
Author details
1Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern,
Bern, Switzerland.
2National Food Administration, Uppsala, Sweden.
3Intervet/
Schering-Plough Animal Health, Milton Keynes, UK.
Authors’ contributions
EMV and AJ made equivalent contributions to the study. EMV carried out
the fluorimetric determination of culture fluid sialidase activity, devised the
cloning strategies and participated in the sequence analysis. He drafted the
manuscript. AJ constructed and screened the genomic library. He carried out
the molecular biological studies and was responsible for expressing the
recombinant sialidases as well as testing the resulting polypeptides in
immunoblotting and sialidase activity spot tests. YS participated in
sequencing and in the immunoassays. KR participated in the design of the
study. JF conceptualized the study and supervised all facets of the research.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 August 2010 Accepted: 11 January 2011
Published: 11 January 2011
References
1. Nagano N, Isomine S, Kato H, Sasaki Y, Takahashi M, Sakaida K, Nagano Y,
Arakawa Y: Human fulminant gas gangrene caused by Clostridium
chauvoei. J Clin Microbiol 2008, 46:1545-1547.
Vilei et al. Veterinary Research 2011, 42:2
http://www.veterinaryresearch.org/content/42/1/2
Page 8 of 92. Sathish S, Swaminathan K: Molecular characterization of the diversity of
Clostridium chauvoei isolates collected from two bovine slaughterhouses:
Analysis of cross-contamination. Anaerobe 2008, 14:190-199.
3. Songer JG: Clostridial diseases of small ruminants. Vet Res 1998,
29:219-232.
4. Hatheway CL: Toxigenic clostridia. Clin Microbiol Rev 1990, 3:66-98.
5. Useh NM, Nok AJ, Esievo KA: Pathogenesis and pathology of blackleg in
ruminants: the role of toxins and neuraminidase. A short review. Vet Q
2003, 25:155-159.
6. Sasaki Y, Kojima A, Aoki H, Ogikubo Y, Takikawa N, Tamura Y: Phylogenetic
analysis and PCR detection of Clostridium chauvoei, Clostridium
haemolyticum, Clostridium novyi types A and B, and Clostridium septicum
based on the flagellin gene. Vet Microbiol 2002, 86:257-267.
7. Sasaki Y, Yamamoto K, Kojima A, Norimatsu M, Tamura Y: Rapid
identification and differentiation of pathogenic clostridia in gas
gangrene by polymerase chain reaction based on the 16S-23S rDNA
spacer region. Res Vet Sci 2000, 69:289-294.
8. Boraston AB, Ficko-Blean E, Healey M: Carbohydrate recognition by a large
sialidase toxin from Clostridium perfringens. Biochemistry 2007,
46:11352-11360.
9. Xu G, Li X, Andrew PW, Taylor GL: Structure of the catalytic domain of
Streptococcus pneumoniae sialidase NanA. Acta Crystallogr Sect F Struct Biol
Cryst Commun 2008, 64:772-775.
10. Newstead S, Chien CH, Taylor M, Taylor G: Crystallization and atomic
resolution X-ray diffraction of the catalytic domain of the large sialidase,
nanI, from Clostridium perfringens. Acta Crystallogr D Biol Crystallogr 2004,
60:2063-2066.
11. Watts AG, Oppezzo P, Withers SG, Alzari PM, Buschiazzo A: Structural and
kinetic analysis of two covalent sialosyl-enzyme intermediates on
Trypanosoma rangeli sialidase. J Biol Chem 2006, 281:4149-4155.
12. Roggentin P, Rothe B, Kaper JB, Galen J, Lawrisuk L, Vimr ER, Schauer R:
Conserved sequences in bacterial and viral sialidases. Glycoconj J 1989,
6:349-353.
13. Vimr ER, Kalivoda KA, Deszo EL, Steenbergen SM: Diversity of microbial
sialic acid metabolism. Microbiol Mol Biol Rev 2004, 68:132-153.
14. Corfield T: Bacterial sialidases–roles in pathogenicity and nutrition.
Glycobiology 1992, 2:509-521.
15. Colman PM: Influenza virus neuraminidase: structure, antibodies, and
inhibitors. Protein Sci 1994, 3:1687-1696.
16. Manco S, Hernon F, Yesilkaya H, Paton JC, Andrew PW, Kadioglu A:
Pneumococcal neuraminidases A and B both have essential roles during
infection of the respiratory tract and sepsis. Infect Immun 2006,
74:4014-4020.
17. Tong HH, Li D, Chen S, Long JP, DeMaria TF: Immunization with
recombinant Streptococcus pneumoniae neuraminidase NanA protects
chinchillas against nasopharyngeal colonization. Infect Immun 2005,
73:7775-7778.
18. Soong G, Muir A, Gomez MI, Waks J, Reddy B, Planet P, Singh PK, Kaneko Y,
Wolfgang MC, Hsiao YS, Tong L, Prince A: Bacterial neuraminidase
facilitates mucosal infection by participating in biofilm production. J Clin
Invest 2006, 116:2297-2305.
19. Mally M, Shin H, Paroz C, Landmann R, Cornelis GR: Capnocytophaga
canimorsus: a human pathogen feeding at the surface of epithelial cells
and phagocytes. PLoS Pathog 2008, 4:e1000164.
20. Tierney DM, Strauss LP, Sanchez JL: Capnocytophaga canimorsus mycotic
abdominal aortic aneurysm: why the mailman is afraid of dogs. J Clin
Microbiol 2006, 44:649-651.
21. Müller HE, Schallehn G: Occurrence of neuraminidase and
acylneuraminat-lyase in Clostridium chauvoei (Clostridium feseri). Zentralbl
Bakteriol Orig A 1972, 222:64-69, (in German).
22. Heuermann D, Roggentin P, Kleineidam RG, Schauer R: Purification and
characterization of a sialidase from Clostridium chauvoei NC08596.
Glycoconjugate J 1991, 8:95-101.
23. Useh NM, Ajanusi JO, Esievo KA, Nok AJ: Characterization of a sialidase
(neuraminidase) isolated from Clostridium chauvoei (Jakari strain). Cell
Biochem Funct 2006, 24:347-352.
24. Pitcher DG, Saunders NA, Owen RJ: Rapid extraction of bacterial genomic
DNA with guanidium thiocyanate. Lett Appl Microbiol 1989, 8:151-156.
25. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA,
Struhl K: Current protocols in molecular biology. New York: John Wiley &
Sons, Inc; 1999.
26. BLAST: Basic local alignment search tool. [http://blast.ncbi.nlm.nih.gov/
Blast.cgi].
27. ExPASy - ProtParam tool. [http://www.expasy.ch/tools/protparam.html].
28. Motif Scan. [http://hits.isb-sib.ch/cgi-bin/motif_scan].
29. InterProScan - Signature recognition search against the integrated
resource of protein domains and functional sites. [http://www.ebi.ac.uk/
Tools/InterProScan/].
30. SignalP 3.0 Server. [http://www.cbs.dtu.dk/services/SignalP/].
31. HMMTOP: Prediction of transmembrane helices and topology of
proteins - Version 2.0. [http://www.enzim.hu/hmmtop/index.html].
32. Phobius - A combined transmembrane topology and signal peptide
predictor. [http://phobius.sbc.su.se/].
33. Align Sequences using ClustalW2 | EBI. [http://www.ebi.ac.uk/Tools/
clustalw2/index.html].
34. Rothe B, Rothe B, Roggentin P, Schauer R: The sialidase gene from
Clostridium septicum: cloning, sequencing, expression in Escherichia coli
and identification of conserved sequences in sialidases and other
proteins. Mol Gen Genet 1991, 226:190-197.
35. Schaller A, Kuhn R, Kuhnert P, Nicolet J, Anderson TJ, MacInnes JI,
Segers RPAM, Frey J: Characterization of apxIVA, a new RTX determinant
of Actinobacillus pleuropneumoniae. Microbiology 1999, 145:2105-2116.
36. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW: Use of T7 RNA
polymerase to direct expression of cloned genes. Methods Enzymol 1990,
185:60-89.
37. Vilei EM, Abdo E-M, Nicolet J, Botelho A, Gonçalves R, Frey J: Genomic and
antigenic differences between the European and African/Australian
clusters of Mycoplasma mycoides subsp. mycoides SC. Microbiology 2000,
146:477-486.
38. Laemmli UK: Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 1970, 227:680-685.
39. Lewin A, Mayer M, Chusainow J, Jacob D, Appel B: Viral promoters can
initiate expression of toxin genes introduced into Escherichia coli. BMC
Biotechnol 2005, 5:19.
40. Moncla BJ, Braham P: Detection of sialidase (neuraminidase) activity in
Actinomyces species by using 2’-(4-methylumbelliferyl)alpha-D-N-
acetylneuraminic acid in a filter paper spot test. J Clin Microbiol 1989,
27:182-184.
41. Munzert E, Müthing J, Büntemeyer H, Lehmann J: Sialidase activity in
culture fluid of Chinese hamster ovary cells during batch culture and its
effect on recombinant human antithrombin III integrity. Biotechnol Prog
1996, 12:559-563.
42. Roggentin P, Krug G, Schauer R, Brasch J: Lack of sialidase activity in
Candida albicans and Candida glabrata. Mycoses 1999, 42:33-36.
43. Berry AM, Lock RA, Paton JC: Cloning and characterization of nanB,a
second Streptococcus pneumoniae neuraminidase gene, and purification
of the NanB enzyme from recombinant Escherichia coli. J Bacteriol 1996,
178:4854-4860.
44. Lock RA, Paton JC, Hansman D: Purification and immunological
characterization of neuraminidase produced by Streptococcus
pneumoniae. Microb Pathog 1988, 4:33-43.
45. Grobe K, Sartori B, Traving C, Schauer R, Roggentin P: Enzymatic and
molecular properties of the Clostridium tertium sialidase. J Biochem 1998,
124:1101-1110.
46. Zenz KI, Roggentin P, Schauer R: Isolation and properties of the natural
and the recombinant sialidase from Clostridium septicum NC 0054714.
Glycoconj J 1993, 10:50-56.
47. Kuhnert P, Capaul S, Nicolet J, Frey J: Phylogenetic positions of Clostridium
chauvoei and Clostridium septicum based on 16S rRNA gene sequences.
Int J Syst Bacteriol 1996, 46:1174-1176.
48. Moussa RS: Antigenic formulae for Clostridium septicum and Clostridium
chauvoei. J Pathol Bact 1959, 77:341-350.
49. Nakatsuji T, Liu YT, Huang CP, Gallo RL, Huang CM: Vaccination targeting a
surface sialidase of P. acnes: implication for new treatment of acne
vulgaris. PLoS ONE 2008, 3:e1551.
50. Long JP, Tong HH, DeMaria TF: Immunization with native or recombinant
Streptococcus pneumoniae neuraminidase affords protection in the
chinchilla otitis media model. Infect Immun 2004, 72:4309-4313.
doi:10.1186/1297-9716-42-2
Cite this article as: Vilei et al.: Genetic and functional characterization of
the NanA sialidase from Clostridium chauvoei. Veterinary Research 2011
42:2.
Vilei et al. Veterinary Research 2011, 42:2
http://www.veterinaryresearch.org/content/42/1/2
Page 9 of 9